Skip to content

Premaitha Health agrees extension with world leader Thermo Fisher Scientific

Calculus Capital portfolio company Premaitha Health Plc (AIM: NIPT), a leading international molecular diagnostics group focused on non-invasive prenatal testing, has announced that it has entered into a further extension of the investment agreement with Thermo Fisher Scientific (“Thermo Fisher”) announced on 14 December 2015 and extended as announced on 23 September 2016, further developing this … Continued

Calculus named finalist for ‘Best EIS Fund’ at Growth Investor Awards 2017

Calculus Capital has been shortlisted for Best EIS Investment Manager at the 2017 Growth Investor Awards, which celebrate the role of the UK’s investment provider community in championing tax-advantaged investments, spotting growth potential and backing outstanding UK small and medium-size enterprises (SMEs). Launched by Intelligent Partnership in 2015, the Growth Investor Awards celebrate the UK’s … Continued